BioTech Medics, Inc. Seeking Testing Of Patented SHBAN Solution As Anti-Viral Disinfectant For Use Against Bird Flu Virus

Published: May 12, 2006

DALLAS, May 12 /PRNewswire/ -- BioTech Medics, Inc., has contacted the Center for Disease Control in Atlanta to seek testing of SHBAN Solution as an anti-viral disinfectant in killing the Avian Influenza, Influenza A (HA & NA) Bird Flu viruses in topical and field use.

The SHBAN(TM) solution, in previous in vitro and in vivo testing has been evaluated for its antimicrobial properties against S. Aureus, S. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa. Tests revealed that SHBAN was extremely effective against all species of bacteria that were tested. Bacterial counts of the test models were reduced to <100 bacteria per gram of tissue in the treated groups, while bacteria counts remained at 6 x 10/5 CFU/GM over 14 days in the untreated control groups.

"We are confident that the SHBAN solution has anti-viral properties that will kill the Avian Influenza virus upon contact without harming humans, animals and the environment," said Delton Carroll, President & CEO of FHJ Scientific and Advisor to BioTech Medics. "SHBAN has previously been tested by Baylor Medical Center in Houston, Louisiana State University, UT Houston, Allergan, Pathology Associates, MBA Labs and Texas A&M College of Veterinary Medicine. When used in diluted dosages SHBAN has tested to be safe around humans and animals and very effective as a germicidal cleaning solution. Upon successful completion of testing, the SHBAN solution will be sold to sanitize infected areas which are currently contaminated with Avian Influenza, such as wildlife bird habitats, poultry farms, duck and geese nesting areas. SHBAN may be considered for preventive measures to spray non-infected areas."

SHBAN is protected under US Letters of Patent #4,868,213, #5,514.808, #5,574,050, #5,679,711 5,679 and #5,585,391.

BioTech Medics will provide SHBAN samples to world health officials to test against Avian Influenza. The public may contact BioTech to acquire SHBAN by calling 972-274-5533.

Contact: Keith Houser, CEO On the Web: Safe Harbor: Forward-Looking Statements.

This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). In Particular, the words "plan," "confident that," "believe" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks, uncertainties and results could differ materially from those expressed in the forward-looking statements.

BioTech Medics, Inc.

CONTACT: Keith Houser, CEO of BioTech Medics, Inc., +1-972-274-5533

Back to news